Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.
M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger
Title and authors | Publication | Year |
---|---|---|
Chronic angiotensin II AT1 receptor blockade increases cerebral cortical microvessel density
DH Munzenmaier, AS Greene |
American journal of physiology. Heart and circulatory physiology | 2005 |
Role of the renin-angiotensin system in the development of the ureteric bud and renal collecting system
IV Yosypiv, SS El-Dahr |
Pediatric Nephrology | 2005 |
Renal Protective Effects of the Renin-Angiotensin-Aldosterone System Blockade: From Evidence-Based Approach to Perspectives
L Tylicki, W Larczynski, B Rutkowski |
Kidney and Blood Pressure Research | 2005 |
Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma
O Arrieta, P Guevara, E Escobar, R García-Navarrete, B Pineda, J Sotelo |
British Journal of Cancer | 2005 |
Differential Effects of Antihypertensive Drugs on Renal and Glomerular Hemodynamics and Injury in the Chronic Nitric-Oxide-Suppressed Rat
X Zhou, ED Frohlich |
American Journal of Nephrology | 2005 |
Tissue-Specific Expression of Renin-Angiotensin System Components in IgA Nephropathy
C Miyake-Ogawa, M Miyazaki, K Abe, T Harada, Y Ozono, H Sakai, T Koji, S Kohno |
American Journal of Nephrology | 2005 |
Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts
C Kampf, T Lau, R Olsson, PS Leung, PO Carlsson |
Diabetologia | 2005 |
Differential expression of angiotensin receptors in human cutaneous wound healing
UM Steckelings, BM Henz, S Wiehstutz, T Unger, M Artuc |
British Journal of Dermatology | 2005 |
Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin–angiotensin system
X Guo, HK Saini, J Wang, SK Gupta, RK Goyal, NS Dhalla |
Expert Review of Cardiovascular Therapy | 2005 |
Angiotensin II receptor 2
S Sheikh, J Hansen |
AfCS-Nature Molecule Pages | 2005 |
Biphasic Effects of Losartan Potassium on Immobility in Mice
P VIJAYAPANDI, AN NAGAPPA |
YAKUGAKU ZASSHI | 2005 |
Telmisartan: from lowering blood pressure to end-organ protection
T Unger, M Schupp |
Future Cardiology | 2005 |
Valsartan in the treatment of hypertension
SE Kjeldsen, HR Brunner, GT McInnes, P Stolt |
Aging Health | 2005 |
Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation
Y Zhao, A Foryst-Ludwig, D Bruemmer, J Culman, M Bader, T Unger, U Kintscher |
Journal of Neurochemistry | 2005 |
The AT2 receptor—A matter of love and hate
UM Steckelings, E Kaschina, T Unger |
Peptides | 2005 |
Ligand-dependent complex formation between the Angiotensin II receptor subtype AT2 and Na+/H+ exchanger NHE6 in mammalian cells
L Pulakat, S Cooper, D Knowle, C Mandavia, S Bruhl, M Hetrick, N Gavini |
Peptides | 2005 |
Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice
H Utsunomiya, M Nakamura, K Kakudo, T Inagami, M Tamura |
Regulatory Peptides | 2005 |
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure
M Blanchet, R Sheppard, N Racine, A Ducharme, D Curnier, JC Tardif, P Sirois, MC Lamoureux, JD Champlain, M White |
American Heart Journal | 2005 |
Effects of oral fixed-dose combinations of telmisartan plus ramipril and losartan plus ramipril in hypertension: A multicenter, prospective, randomized, double-blind, phase iii trial in adult indian patients
SD Jain, S Biradar, I Periyandavar, SS Sodhi, K Anwaruddin, A Gawde, V Baliga, K Gandewar, A Desai |
Current Therapeutic Research | 2005 |
Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide: Effects of Ang II on ovine fetoplacental endothelium
J Zheng, IM Bird, DB Chen, RR Magness |
The Journal of Physiology | 2005 |
Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing
C Warnecke, P Mugrauer, D Sürder, J Erdmann, C Schubert, V Regitz-Zagrosek |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2005 |
AT 2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT 1 receptor antagonism in conscious normotensive but not hypertensive rats
LM Duke, RG Evans, RE Widdop |
American journal of physiology. Heart and circulatory physiology | 2005 |
Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT 1 -receptor blocker over thiazide alone on renoprotection in l -NAME/SHR
X Zhou, LC Matavelli, H Ono, ED Frohlich |
American journal of physiology. Renal physiology | 2005 |
ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain
A Blume, C Undeutsch, Y Zhao, E Kaschina, J Culman, T Unger |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2005 |
Constitutively Active Homo-oligomeric Angiotensin II Type 2 Receptor Induces Cell Signaling Independent of Receptor Conformation and Ligand Stimulation
S Miura, SS Karnik, K Saku |
The Journal of biological chemistry | 2005 |
Neuroprotection with Angiotensin Receptor Antagonists: A Review of the Evidence and Potential Mechanisms
H Wilms, P Rosenstiel, T Unger, G Deuschl, R Lucius |
American Journal Cardiovascular Drugs | 2005 |
Angiotensin Antagonism in Coronary Artery Disease: Results after Coronary Revascularisation
F Ribichini, V Ferrero, A Rognoni, G Vacca, C Vassanelli |
Drugs | 2005 |
Interstitial Fibrosis in Heart Failure
FJ Villarreal |
2005 | |
Mechanisms of Angiogenesis
M Clauss, G Breier |
2005 |